Holiday Sale | Save 50%
SubscribeLogin
Holiday Sale | Save 50%
Published

Granules India's Generic ADHD Drug Gets FDA Nod

Summary by NDTV Profit
Drug maker Granules India Ltd. announced on Tuesday that its subsidiary, Granules Pharmaceuticals Inc., has received approval from the US Food and Drug Administration for a generic version of a medication used to treat attention-deficit hyperactivity disorder.The approval pertains to GPI's abbreviated new drug application for Lisdexamfetamine Dimesylate chewable tablets, the company said in an exchange filing. The generic product will be availab…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

BusinessBusiness
FinanceFinance
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal